These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10075094)

  • 1. Evaluation of the effect of thyroxine supplementation on behavioural outcome in very preterm infants.
    Briët JM; van Wassenaer AG; van Baar A; Dekker FW; Kok JH
    Dev Med Child Neurol; 1999 Feb; 41(2):87-93. PubMed ID: 10075094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
    Ng SM; Turner MA; Weindling AM
    Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid function in very preterm newborns: possible implications.
    Van Wassenaer AG; Kok JH; Briët JM; Pijning AM; de Vijlder JJ
    Thyroid; 1999 Jan; 9(1):85-91. PubMed ID: 10037082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
    Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
    Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
    van Wassenaer AG; Westera J; Houtzager BA; Kok JH
    Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial.
    Ng SM; Turner MA; Gamble C; Didi M; Victor S; Manning D; Settle P; Gupta R; Newland P; Weindling AM
    Trials; 2013 Jul; 14():211. PubMed ID: 23841945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants.
    van Wassenaer AG; Briët JM; van Baar A; Smit BJ; Tamminga P; de Vijlder JJ; Kok JH
    Pediatrics; 2002 Sep; 110(3):534-9. PubMed ID: 12205256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
    van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
    N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor nerve conduction velocity in very preterm infants in relation to L-thyroxine supplementation.
    Smit BJ; Kok JH; de Vries LS; van Wassenaer AG; Dekker FW; Ongerboer de Visser BW
    J Pediatr; 1998 Jan; 132(1):64-9. PubMed ID: 9470002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quality of preterm infants' spontaneous movements: an early indicator of intelligence and behaviour at school age.
    Butcher PR; van Braeckel K; Bouma A; Einspieler C; Stremmelaar EF; Bos AF
    J Child Psychol Psychiatry; 2009 Aug; 50(8):920-30. PubMed ID: 19457048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial.
    Ment LR; Vohr B; Allan W; Westerveld M; Sparrow SS; Schneider KC; Katz KH; Duncan CC; Makuch RW
    Pediatrics; 2000 Mar; 105(3 Pt 1):485-91. PubMed ID: 10699097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental outcome of nutritional intervention in newborn infants at risk of neurodevelopmental impairment: the Dolphin neonatal double-blind randomized controlled trial.
    Andrew MJ; Parr JR; Montague-Johnson C; Laler K; Holmes J; Baker B; Sullivan PB
    Dev Med Child Neurol; 2018 Sep; 60(9):897-905. PubMed ID: 29806081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates.
    Kelleher AS; Clark RH; Steinbach M; Chace DH; Spitzer AR;
    J Perinatol; 2008 Apr; 28(4):270-4. PubMed ID: 18288119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group.
    Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK
    N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction.
    Roze E; Van Braeckel KN; van der Veere CN; Maathuis CG; Martijn A; Bos AF
    Pediatrics; 2009 Jun; 123(6):1493-500. PubMed ID: 19482759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroxine for transient hypothyroxinemia and cerebral palsy in extremely preterm infants.
    Suzumura H; Nitta A; Tsuboi Y; Watabe Y; Kuribayashi R; Arisaka O
    Pediatr Int; 2011 Aug; 53(4):463-7. PubMed ID: 21054676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone: treatment effect according to gestational age at birth.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F30-F35. PubMed ID: 29321180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome.
    Biswas S; Buffery J; Enoch H; Bland JM; Walters D; Markiewicz M
    Pediatrics; 2002 Feb; 109(2):222-7. PubMed ID: 11826199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks' gestation at birth.
    Miller SP; Mayer EE; Clyman RI; Glidden DV; Hamrick SE; Barkovich AJ
    Pediatrics; 2006 May; 117(5):1626-31. PubMed ID: 16651316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.